Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014855 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O4 |
| Mol.Wt. | 418.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014856 |
| CAS No | NA |
| Mol.F. | C22H26N4O6 |
| Mol.Wt. | 442.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014857 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014858 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014859 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014860 |
| CAS No | NA |
| Mol.F. | C20H23FN4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014861 |
| CAS No | NA |
| Mol.F. | C9H13N3O |
| Mol.Wt. | 179.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014862 |
| CAS No | NA |
| Mol.F. | C14H16N4O |
| Mol.Wt. | 256.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014863 |
| CAS No | 146897-60-1 |
| Mol.F. | C8H8N2O3 |
| Mol.Wt. | 180.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014864 |
| CAS No | 938-81-8 |
| Mol.F. | C8H8N2O2 |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014865 |
| CAS No | NA |
| Mol.F. | C12H10N2O3 |
| Mol.Wt. | 230.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014866 |
| CAS No | NA |
| Mol.F. | C4H10N6O |
| Mol.Wt. | 158.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014867 |
| CAS No | NA |
| Mol.F. | C2H3N5O |
| Mol.Wt. | 113.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014868 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014869 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014870 |
| CAS No | NA |
| Mol.F. | C10H6N2O4 |
| Mol.Wt. | 218.2 |
| INV STATUS | CUSTOM SYNTHESIS |